adult patients
- Technology
DBT inputs regarding efforts to ramp up oxygen supply
AMTZ through the DBT–BIRAC Command consortium and two start-ups of BIRAC network of incubators are manufacturing oxygen concentrators including oxygen enrichment based on Pressure swing…
Read More » - Health
U.S. FDA Approves Supplemental New Drug Application for Takeda’s ICLUSIG® (ponatinib) for Adult Patients with Resistant or Intolerant Chronic-Phase CML
Osaka, Japan & Cambridge, Mass., United States: – Updated ICLUSIG Label will Prove Practice-Changing, Expanding Indication to CP-CML Patients with Resistance…
Read More » - Health
Phase II trial results demonstrated improvement in cognition with BI 425809 in adult patients with schizophrenia
Ingelheim, Germany: Results presented at the 33rd ECNP Congress from a 12-week, placebo-controlled Phase II trial demonstrated BI 425809 has…
Read More »